Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending December 06, 2007. The report details a specific corporate action regarding the repurchase and cancellation of the company's ordinary shares, executed under authority granted by shareholders at the Annual General Meeting on May 23, 2007.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase transaction:
- Shares Purchased: 2,275,000 ordinary shares of 25 pence each.
- Purchase Price: 1,300.5894 pence per share.
- Treasury Shares Held: 504,194,158 shares (representing 9.15% of total voting rights).
- Shares in Issue: 5,512,708,343 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of the company's share capital through the cancellation of 2,275,000 repurchased shares. Consequently, the number of shares held in Treasury has increased to 504,194,158. The filing does not report material changes to operational performance or financial position compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Key Facts for Investor Verification
- Verify the total cost of the repurchase transaction based on the disclosed price of 1,300.5894 pence per share.
- Confirm the updated share count of 5,512,708,343 shares in issue for calculating ownership percentages under Disclosure Transparency Rules.
- Note that 9.15% of total voting rights are now held in Treasury and are excluded from the shares in issue count.
- Recognize that this filing is a regulatory disclosure of a capital transaction and does not contain quarterly or annual financial performance data.